Completed
Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
NCT04519567
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
- Locations
-
- Clinilabs Drug Development Corporation Eatontown, New Jersey, United States